Articles de revue sur le cancer du sein - Dernières parutions

InTextoResearch, agence d'information scientifique


InTextoResearch informe sur les dernières parutions d'articles de
revue sur le cancer du sein:


Surveillance mammography following the treatment of primary breast
cancer with breast reconstruction: a systematic review.
Barnsley GP, Grunfeld E, Coyle D, Paszat L.
Plast Reconstr Surg. 2007 Oct;120(5):1125-32.

A role for biomarkers in the screening and diagnosis of breast cancer
in younger women.
Esserman LJ, Shieh Y, Park JW, Ozanne EM.
Expert Rev Mol Diagn. 2007 Sep;7(5):533-44.

Sentinel lymph node biopsy for breast cancer.
Sato K, Shigenaga R, Ueda S, Shigekawa T, Krag DN.
J Surg Oncol. 2007 Sep 15;96(4):322-9.

Mechanisms of disease: angiogenesis and the management of breast
cancer.
Banerjee S, Dowsett M, Ashworth A, Martin LA.
Nat Clin Pract Oncol. 2007 Sep;4(9):536-50.

Origins of breast cancer subtypes and therapeutic implications.
Sims AH, Howell A, Howell SJ, Clarke RB.
Nat Clin Pract Oncol. 2007 Sep;4(9):516-25.

Modelling breast cancer: one size does not fit all.
Vargo-Gogola T, Rosen JM.
Nat Rev Cancer. 2007 Sep;7(9):659-72.

The association between allergies and cancer: what is currently known?
Merrill RM, Isakson RT, Beck RE.
Ann Allergy Asthma Immunol. 2007 Aug;99(2):102-16

Lapatinib: a tyrosine kinase inhibitor with a clinical role in breast
cancer.
Mukherjee A, Dhadda AS, Shehata M, Chan S.
Expert Opin Pharmacother. 2007 Sep;8(13):2189-204.

Steroid receptor RNA activator (SRA1): unusual bifaceted gene products
with suspected relevance to breast cancer.
Leygue E.
Nucl Recept Signal. 2007 Aug 3;5:e006.

Letrozole: present and future role in the treatment of breast cancer.
Amar S, Roy V, Perez EA.
Expert Opin Pharmacother. 2007 Aug;8(12):1965-75.

Tissue culture as a hostile environment: identifying conditions for
breast cancer progression studies.
Shay JW, Wright WE.
Cancer Cell. 2007 Aug;12(2):100-1.

Raloxifene: cardiovascular considerations.
Abu Fanne R, Brzezinski A, Danenberg HD.
Mini Rev Med Chem. 2007 Aug;7(8):871-6.

Nutritional modulation of terminal end buds: its relevance to breast
cancer prevention.
Hilakivi-Clarke L.
Curr Cancer Drug Targets. 2007 Aug;7(5):465-74.

Trastuzumab-related cardiotoxicity: calling into question the concept
of reversibility.
Telli ML, Hunt SA, Carlson RW, Guardino AE.
J Clin Oncol. 2007 Aug 10;25(23):3525-33.

Schwannoma of the breast: a case report and review of the literature.
Bellezza G, Lombardi T, Panzarola P, Sidoni A, Cavaliere A, Giansanti
M.
Tumori. 2007 May-Jun;93(3):308-11.

Rehabilitation in women with breast cancer.
Silver JK.
Phys Med Rehabil Clin N Am. 2007 Aug;18(3):521-37

The emerging role of the LIV-1 (SLC39A6) subfamily of zinc
transporters in breast cancer..
Taylor KM, Morgan HE, Smart K, Zahari NM, Pumford S, Ellis IO,
Robertson JF, Nicholson RI.
Mol Med. 2007 Jul-Aug;13(7-8):396-406.

Dendritic cell vaccination.
Proudfoot O, Pouniotis D, Sheng KC, Loveland BE, Pietersz GA.
Expert Rev Vaccines. 2007 Aug;6(4):617-33.

Targeting HER proteins in cancer therapy and the role of the non-
target HER3.
Hsieh AC, Moasser MM.
Br J Cancer. 2007 Aug 20;97(4):453-7.

Viruses and human breast cancer.
Lawson JS, Günzburg WH, Whitaker NJ.
Future Microbiol. 2006 Jun;1:33-51.

Cardiac safety of liposomal anthracyclines.
Batist G.
Cardiovasc Toxicol. 2007;7(2):72-4.

Anthracycline cardiotoxicity in breast cancer patients: synergism with
trastuzumab and taxanes.
Gianni L, Salvatorelli E, Minotti G.
Cardiovasc Toxicol. 2007;7(2):67-71.

Drug insight: breast cancer prevention and tissue-targeted hormone
replacement therapy.
Labrie F.
Nat Clin Pract Endocrinol Metab. 2007 Aug;3(8):584-93.

Metallographic in situ hybridization.
Powell RD, Pettay JD, Powell WC, Roche PC, Grogan TM, Hainfeld JF,
Tubbs RR.
Hum Pathol. 2007 Aug;38(8):1145-59.

Chromogenic and fluorescent in situ hybridization in breast cancer.
Lambros MB, Natrajan R, Reis-Filho JS.
Hum Pathol. 2007 Aug;38(8):1105-22.

Development of vaccines for high-risk ductal carcinoma in situ of the
breast.
Czerniecki BJ, Roses RE, Koski GK.
Cancer Res. 2007 Jul 15;67(14):6531-4.

Gene expression profiles and prognostic markers for primary breast
cancer.
Wang Y, Klijn J, Zhang Y, Atkins D, Foekens J.
Methods Mol Biol. 2007;377:131-8.

Molecularly targeted therapeutics for breast cancer.
Hussain SA, Palmer DH, Spooner D, Rea DW.
BioDrugs. 2007;21(4):215-24.


(contact à InTextoResearch: Marc Lacroix, Baelen, Wallonie, Belgique -
scimedweb@mail.com)